“ANALYSIS OF RISK FACTORS AND TREATMENT PHASES ON THE SEVERITY OF HEPATOTOXICITY DUE TO ANTI-TUBERCULOSIS DRUGS”, JIIS, vol. 11, no. 1, pp. 240–249, Mar. 2026, doi: 10.36387/jiis.v11i1.2911.